AE Wealth Management »

Galectin Therapeutics shares owned by AE Wealth Management

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by AE Wealth Management from 13F filings

Historical chart of AE Wealth Management investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by AE Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by AE Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $46k 27k 1.73
2023-09-30 $52k 27k 1.92
2023-06-30 $22k 16k 1.44
2023-03-31 $33k 16k 2.10
2022-12-31 $18k 16k 1.13

More positions owned by AE Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Ishares Tr Rus Tp200 Gr Etf (IWY)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Sustainabilty (DFSU)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Aim Etf Products Trust Us Lrgcp B20 Jan (JANW)
Vanguard Index Fds Growth Etf (VUG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus Tp200 Vl Etf (IWX)

View all positions for AE Wealth Management

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
Geneos Wealth Management
Atria Wealth Solutions
Sontag Advisory
Cambridge Investment Research Advisors
Commonwealth Equity Services
Cutter & CO Brokerage
683 Capital Management
Horizon Kinetics Asset Management
D.A. Davidson & Co.
Stratos Wealth Partners
William Blair $ Company
Independent Advisor Alliance
Solutions 4 Wealth

View all funds holding Galectin Therapeutics